SCHEMBL24664430

SCHEMBL24664430

CCNC(=O)N1CC(F)(F)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.59
HTT P42858 2/20 0.50
DPP4 P27487 1/20 0.36
FAAH O00519 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
TSHR P16473 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPK1 P28482 1/20 0.35
MTOR P42345 1/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
RORC P51449 2/20 0.34
NR1I2 O75469 1/20 0.34
RIPK1 Q13546 3/20 0.33
KCNK3 O14649 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20307157 0.85 KMT2A (0.57) KMT2AHTTDPP4FAAHCYP3A4
SCHEMBL17055653 0.82 KMT2A (0.53) KMT2AHTTDPP4CYP2D6TSHR
SCHEMBL24666468 0.80 CYP2C19 (0.43) KMT2ADPP4CYP2D6KDM4E
SCHEMBL23081643 0.79 KMT2A (0.59) KMT2AHTTDPP4FAAHCYP3A4
SCHEMBL24922922 0.79 KMT2A (0.53) KMT2AHTTDPP4FAAHCYP3A4
SCHEMBL24666007 0.78 RBP4 (0.36) KMT2ADPP4
SCHEMBL17113706 0.76 POLB (0.54) DPP4RIPK1
SCHEMBL23075987 0.75 KMT2A (0.53) KMT2AHTTDPP4FAAHCYP3A4
SCHEMBL24567549 0.75 KDM4E (0.44) KMT2ADPP4MEN1SMN1; SMN2RIPK1
SCHEMBL24848503 0.75 KMT2A (0.53) KMT2AHTTDPP4ALOX12SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059665-A1 DIMERIC COMPOUNDS AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-03-21 WO disclosed
WO-2022198196-A1 INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2022-09-22 WO disclosed
EP-4053110-A1 MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2022-09-07 EP disclosed